MANAGE-AF Registry -MANAGEment of Atrial Fibrillation Outcomes Registry (MANAGE-AF)

Launched by CORVITA SCIENCE FOUNDATION · Jul 28, 2023

Keywords

ClinConnect Summary

The MANAGE-AF Registry is a research study aimed at understanding how patients with atrial fibrillation (AF) are treated in real-world settings. Atrial fibrillation is a condition that causes irregular heartbeats, which can increase the risk of blood clots and strokes. This study will help doctors learn about different treatment approaches that patients receive, including medications and procedures, and how these approaches may vary from one doctor or hospital to another. By gathering this information, the researchers hope to improve care for patients with AF.

To be eligible for the study, participants must be at least 18 years old and have a confirmed diagnosis of atrial fibrillation, either related to heart valve problems or not. They should also be able to attend follow-up appointments at the research clinic at least once a year. If someone joins the study, they can expect regular check-ins to track their heart health and treatment progress. This research is important for finding the best ways to manage atrial fibrillation and enhance the overall care for patients living with this condition.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • 1. Diagnosis of valvular or non valvular atrial fibrillation
• • 2. ECG documented atrial fibrillation A. 12 lead B. Rhythm strip C. Event monitor D. Holter Monitor E. Implantable loop recorder
• Exclusion Criteria:
• • 1. Age below 18 years.
• • 2. Clinical evidence that death within 6 months is possible
• • 3. Inability to consent to the research or sign a consent form
• • 4. Inability to follow up at the research clinic at least annually for continuity of AF care and management